Teva Promotes Notes Excluding UK in Compliance Move

TEL AVIV, Israel, Sept. 07, 2026 /CourierPR/ -- Teva Pharmaceutical Industries Ltd has issued a press release regarding the promotion of its Notes in certain international markets, excluding the United Kingdom. The company has taken steps to ensure the issuance and distribution comply with local financial regulations and laws.

The release highlights that the Notes are being marketed and promoted to a specific audience, including investment professionals, high net worth entities, and other relevant persons as defined by the Financial Services and Markets Act 2000 (FSMA) in the United Kingdom. Teva has carefully structured the promotion to ensure compliance with the UK's financial promotion rules, which restrict the issuance of such financial instruments to the general public.

In other jurisdictions, Teva's Notes are being offered to qualified investors, in line with local regulatory requirements. The company has explicitly stated that the Notes are not being promoted to the general public in the Netherlands or Israel, further emphasizing its commitment to adhering to international financial regulations.

The press release reiterates Teva's dedication to maintaining compliance with global financial regulations, ensuring that its issuance of Notes is conducted in a manner that respects local legal frameworks. By adhering to these stringent guidelines, Teva aims to safeguard the interests of its stakeholders and maintain its reputation for integrity and compliance in the global financial market.

This move by Teva underscores its ongoing efforts to expand its financial operations while adhering to the regulatory landscape. As the pharmaceutical industry continues to evolve, such steps are essential for companies like Teva to navigate the complexities of international financial markets effectively.